April 19, 2007
Teva Faces Lawsuit Over Clinical Trial
Proneuron Biotechnologies, an Israeli biotech, is alleging that Teva Pharmaceutical Industries is deliberately conducting a clinical trial of a drug to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) that is very unlikely to succeed.
Subscribers: click here for the full story
Non-Subscribers: click here to subscribe
Pay per view ($10.00)
http://www.fdanews.com/cta/12_8/cour...ml?CMP=OTC-RSS